Skip to main navigation Skip to search Skip to main content

Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments

Press/Media

PeriodJan 15 2024

Media coverage

1

Media coverage